Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 01-2017 | 10-2016 | 09-2016 | 07-2016 | 06-2016 | |
| Sales | 248 | 197 | 7 | 975 | 7 |
| Gross Profit | 248 | 197 | 7 | 975 | 7 |
| Operating Expenses | 8,365 | 4,222 | 2,412 | 6,095 | 6,971 |
| Operating Income | -8,117 | -4,025 | -2,405 | -5,120 | -6,964 |
| Interest Expense | 0 | 0 | 0 | 0 | 406 |
| Other Income | 473 | 730 | 20 | 1,683 | 20 |
| Pre-tax Income | -7,644 | -3,295 | -2,385 | -3,437 | -7,350 |
| Net Income Continuous | -7,644 | -3,295 | -2,385 | -3,437 | -7,350 |
| Net Income | $-7,644 | $-3,295 | $-2,385 | $-3,437 | $-7,350 |
| EPS Basic Total Ops | -1.03 | -5.98 | -1.26 | -6.66 | -3.92 |
| EPS Basic Continuous Ops | -1.00 | -4.64 | -1.27 | -5.12 | -3.91 |
| EPS Diluted Total Ops | -1.03 | -5.98 | -1.26 | -6.66 | -3.92 |
| EPS Diluted Continuous Ops | -1.00 | -4.64 | -1.27 | -5.12 | -3.91 |
| EBITDA(a) | $-8,088 | $-3,999 | $-2,405 | $-5,120 | $-6,873 |